Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Data by

Global Data

23

Revenue 2014

Biogen Idec

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Biogen Idec's 2013 Oncology and CNS sales performance.

UK trumpets life sciences post-Brexit ‘sector deal’

UK trumpets life sciences post-Brexit ‘sector deal’

with the European Bioinformatics Institute, the Wellcome Trust Sanger Institute, Biogen and Takeda that makes genetic and biological data freely available to researchers.

First Herceptin biosimilar cleared in Europe

First Herceptin biosimilar cleared in Europe The South Korea-based joint venture between Samsung and Biogen says the new biosimilar, called Ontruzant, has been approved for the full range of registered indications for Herceptin (trastuzumab), including early

New data could unlock bigger market for Roche’s Hemlibra

New data could unlock bigger market for Roche’s Hemlibra Haemophilia A treatment is being transformed by a series of long-acting Factor VIII products such as Biogen’s Eloctate, Shire’s Adynovate, Bayer’s Kovaltry and CSLBehring’s Afstyla, which

Sanofi licences Principia MS drug in $805m deal

Sanofi licences Principia MS drug in $805m deal Sanofi ‘s established oral MS therapy is Aubagio (teriflunomide), which got off to a slow start after its launch in 2012 in the face of competition from rival drugs from Biogen ... With a 27% growth it is still one of Sanofi’s most important products,

Constellation Pharmaceuticals completes management team with two new-hires

Constellation Pharmaceuticals completes management team with two new-hires His experience has seen him spend ten years at Cubist Pharmaceuticals, Biogen and Covance.

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ()

Global Data Data by GlobalData

GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.

To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

Grabbing your audience*
Highlighting one of our recent pieces of work - a powerful disease awareness film created in partnership with Watchable Films...
Defining Market Access and the Key to Success
Kevin Lennon, Head of Operations & Market Access at OUTiCO, shares his definition of market access and the key to success....
the_other_side_of_multiple_sclerosis_thumb.jpg
THE OTHER SIDE OF … MULTIPLE SCLEROSIS
“My sister went without treatment despite relapses - enough was enough, I had to intervene”...

Infographics